BioSpace News Archive

Dicerna retains the right to opt into two clinical-stage programs to be derived from the discovery collaboration.

Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, announced today that it will refocus the company on healthcare, change its name to Precigen, Inc. and, effective immediately, has appointed Helen Sabzevari, PhD, as President and CEO.

This collaboration will be carried out under a Cooperative Research and Development Agreement between Opiant and the NIH.

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), announced that results from a Phase 2 study evaluating AKCEA-APO(a)-LRx, also known as TQJ230,

Cardinal Health (NYSE: CAH) plans to release second quarter financial results for its fiscal year 2020 on Feb. 6 prior to the opening of trading on the New York Stock Exchange.

CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E investment led by New Alliance Capital

Agilent Technologies Inc. (NYSE: A) today announced the latest implementation of its mutual compatibility philosophy

Diomics Corporation, a leader in forensic, diagnostic, and therapeutic science since 2009, and the laboratory of Dr. Jonathan Lakey, Professor of Surgery and Biomedical Research and Director of the Clinical Islet Program at the University of California, Irvine (UCI), today announced a Sponsored Research Agreement to ultimately improve islet transplantation for patients living with type 1 diabetes.

Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report fourth quarter and 2019 financial results on Wednesday, January 29, 2020, after the close of market.

The new Agritek Holdings and acquisition of the Apex distribution licensed division will allow the Company to join forces to launch the “Higher Society” premium cannabis brand initially in California in order to drive revenue for both companies.